ENGN

The current price of enGene Therapeutics Inc. Common Stock (ENGN) is 1.91. Over the past 24 hours, the stock has changed by -2.05%. Follow the ENGN chart for real-time price dynamics.

enGene Therapeutics Inc. Common Stock trades under the ticker ENGN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

ENGN has changed by +6.11% over the last week, +10.40% over the last month, and -77.26% over the last year. Review the chart to see whether the current move is part of a broader trend.

enGene Therapeutics Inc. Common Stock currently has a market capitalization of 127.95 M. Market capitalization reflects the total market value of a company's outstanding shares and is commonly used to compare companies by size.

Yes. You can track enGene Therapeutics Inc. Common Stock financial reports and review yearly or quarterly fundamentals on metatrader.com, including revenue, net income, dividends, and valuation metrics.

Last quarter, enGene Therapeutics Inc. Common Stock reported earnings of -0.43 per share. Earnings per share is one of the key metrics investors use to evaluate a company's profitability and financial performance.

enGene Therapeutics Inc. Common Stock reported quarterly revenue of 29 K. Revenue is one of the main indicators used to evaluate the company's business growth and operating scale.

enGene Therapeutics Inc. Common Stock reported net income of -30.23 M for the last quarter. The previous quarter showed -29.75 M, which means net income changed by -1.60%.

enGene Therapeutics Inc. Common Stock paid a dividend per share of 0. The current dividend yield is 0%. Dividend data can help income-focused investors evaluate the stock.

As of the latest available data, enGene Therapeutics Inc. Common Stock has 82 employees. Workforce size can provide additional context about the company's scale and operations.

enGene Therapeutics Inc. Common Stock EBITDA is -31.74 M, and its EBITDA margin is -109.44 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.

You can buy enGene Therapeutics Inc. Common Stock (ENGN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Investing in enGene Therapeutics Inc. Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the ENGN chart and related analysis on metatrader.com as part of your research.